Skip to main content
Premium Trial:

Request an Annual Quote

MGI Tech Partners With Sweden's Xpress Genomics on Single-Cell RNA-seq Tech Development

NEW YORK – China's MGI Tech said on Wednesday that it has partnered with Stockholm-based Xpress Genomics to develop single-cell RNA-sequencing technology.

Under the terms of the agreement, MGI has licensed single-cell RNA-seq techniques that cover the full length of a transcript from Xpress Genomics.

"We are excited to finally unify quality and scale with our full-length scRNA-seq solutions," said Rickard Sandberg, cofounder of Xpress Genomics and a professor at the Karolinska Institute. "Building on our longstanding experience in this area, the developed technology will be streamlined into MGI's sequencing technology for the most cost-efficient and scalable full-length scRNA-seq to date."

Financial and other terms of the deal were not disclosed.

Xpress Genomics has a lab at the Cancer Center Karolinska in Sweden.

The Scan

Cystatin C Plays Role in Immunosuppression, Cancer Immunotherapy Failure, Study Finds

A study in Cell Genomics provides insight into how glucocorticoids can lead to cancer immunotherapy failure via cystatin C production.

Aging, Species Lifespan Gene Expression Signatures Overlap

An Osaka Metropolitan University team reports in Nucleic Acids Research that transcriptional signatures of aging and maximum lifespan have similarities.

Splicing Subgroup Provides Protocols for Evaluating Splicing Variant Data

The group presents their approach on how to apply evidence codes to splicing predictions and other data in the American Journal of Human Genetics.

Single-Cell Transcriptomic Atlas of Mouse Cochlea to Aid Treatment Development

Researchers in PNAS conducted single-cell and single-nuclear sequencing of about 120,000 cells at three key timepoints in cochlear development to generate a transcriptomic atlas.